PharmExec

CONTINUE TO SITE

OR WAIT null SECS

Advertisement

PharmExec Emerging Pharma Leaders Nominations Now Open!2022 Pharmaceutical Executive APEX Award Winners

PharmExec Emerging Pharma Leaders Nominations Now Open!2022 Pharmaceutical Executive APEX Award Winners

View More Executive Profiles R&D/Clinical Trials Strategy Supply Chain Technology

Executive ProfilesR&D/Clinical TrialsStrategySupply ChainTechnology

Pharm Exec Podcasts Pharm Exec Video

Pharmaceutical Executive

E-Books Events Sponsored Podcasts Sponsored Videos Webcasts Whitepapers

E-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

EnewsMagazine

Advertise
Contact Editorial
Editorial Submission Guidelines
Contact MJH Life Sciences
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.

Spotlight

PharmExec Emerging Pharma Leaders Nominations Now Open!
2022 Pharmaceutical Executive APEX Award Winners

Executive Profiles
R&D/Clinical Trials
Strategy
Supply Chain
Technology

Advertise
Contact Editorial
Editorial Submission Guidelines
Contact MJH Life Sciences
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

© 2023 MJH Life Sciences^™ and Pharmaceutical Executive. All rights reserved.

Lynn Russo, JD, PhD

home

Articles

IP and COVID-19

Disputes over mRNA-related patents are poised to persist.